ArticleHaematologica2014

The gene signature in CCAAT-enhancer-binding protein α dysfunctional acute myeloid leukemia predicts responsiveness to histone deacetylase inhibitors.

Adam Liss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.